Novolin N (Insulin NPH): Dosing Principles, Safety, and Monitoring

What Is Novolin N?

Novolin N is an intermediate-acting human insulin (NPH – Neutral Protamine Hagedorn). Onset: 1–2 h; Peak: 4–12 h; Duration: 12–18 h. Cloudy suspension – must roll gently to mix.

Dosing Principles (General – Individualized by Clinician)

  • Basal insulin: Usually once or twice daily (bedtime + morning, or dinner + bedtime).
  • Starting dose: 0.1–0.2 units/kg/day (e.g., 10–20 units for 100 kg person).
  • Titration: Adjust by 10–20% or 2–4 units every 3–7 days based on fasting glucose trends.
  • Target fasting glucose: 80–130 mg/dL (individualized).

Critical Safety Points

  • Hypoglycemia risk: Peak effect ~4–12h post-injection. Nighttime hypoglycemia common with bedtime dosing. Symptoms: tremor, sweat, hunger, confusion, seizure, coma.
  • Rule of 15: If <70 mg/dL → 15g fast carb → recheck 15 min.
  • Glucagon kit / Baqsimi / Gvoke: Prescribed for severe lows.
  • Never share pens/vials.
  • Sick day rules: Check glucose q4h, never stop insulin, hydrate, check ketones if >250 mg/dL.

Comparison

Monitoring

  • SMBG: fasting, pre-meal, bedtime, occasional 3 AM.
  • CGM: highly recommended for insulin users.
  • HbA1c q3–6 months.

Always coordinate dosing changes with your diabetes care team. This overview is educational, not a prescription.

Diabetes - Related Articles

Health Sciences © https://www.222health.com

Novolin N (NPH)Basal Analogs (Glargine U100/U300, Degludec)
PeakYes (4–12h)Minimal/flat
Hypoglycemia riskHigher (esp. nocturnal)Lower
CostLower (OTC in some states)Higher
FlexibilityFixed timing criticalFlexible timing (±3h)